Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Pfizer, Inc. patentsThe following is a sampling of recent Pfizer, Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
August 2011 - Pfizer, Inc. patents
20110190326 - Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions
July 2011 - Pfizer, Inc. patents
20110184652 - Methods of generating genetic predictors employing dna markers and quantitative trait data
20110174305 - Device for dispensing a plurality of unitary doses of dry powder, and inhaler comprising such device
20110178042 - Hydroxamic acid derivatives useful as antibacterial agents
20110178165 - Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof
20110172443 - Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, alpha-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
20110165170 - Osteopontin antibodies
20110166120 - Sulfonyl amide derivatives for the treatment of abnormal cell growth
June 2011 - Pfizer, Inc. patents
20110150913 - Torque teno virus (ttv) isolates and compositions
20110136765 - Pyrrolo[2,3-d]pyrimidine compounds
May 2011 - Pfizer, Inc. patents
20110123983 - Methods of using genetic markers and related epistatic interactions
20110118476 - Process for preparing chiral compounds
20110112100 - Hepatitis c virus inhibitors
20110104182 - Cd40 antibody formulation and methods
20110105533 - Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
20110105600 - Synergistic composition of (-)-hydroxycitric acid with monoterpene and a method to enhance satiety
April 2011 - Pfizer, Inc. patents
20110097341 - Treatment of chronic prostatitis
20110092480 - Substituted heterocyclic derivatives and their pharmaceutical use and compositions
20110092529 - 1,2,4-triazole derivatives and their use as oxytocin antagonists
March 2011 - Pfizer, Inc. patents
20110053950 - 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
February 2011 - Pfizer, Inc. patents
20110044985 - Antibodies directed against amyloid-beta peptide and methods using same
20110039856 - Polymorphs of a c-met/hgfr inhibitor
20110033441 - Pyrimidine derivatives for the treatment of abnormal cell growth
20110034529 - Benzene, pyridine, and pyridazine derivatives
20110027262 - Platform antibody compositions
December 2010 - Pfizer, Inc. patents
20100324061 - Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
20100324066 - Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same
November 2010 - Pfizer, Inc. patents
20100298767 - particle cassettes
20100291076 - Antibodies specific for dkk-1 and their uses
October 2010 - Pfizer, Inc. patents
20100256357 - Heterocycles useful as inhibitors of carbonic anhydrase
September 2010 - Pfizer, Inc. patents
20100249128 - Novel 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
20100222342 - Pyrrolopyrazole, potent kinase inhibitors
August 2010 - Pfizer, Inc. patents
20100196390 - Agonist anti-trkb monoclonal antibodies
July 2010 - Pfizer, Inc. patents
20100190977 - 4-phenylamino-quinazolin-6-yl-amides
20100184737 - Imidazole compounds for the treatment of neurological disorders
20100179329 - Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole suitable for the treatment of abnormal cell growth in mammals
20100168107 - Imidazole compounds for the treatment of neurodegenerative disorders
June 2010 - Pfizer, Inc. patents
20100158933 - Ige ch3 peptide vaccine
20100137279 - 4-methylpyridopyrimidinone compounds
May 2010 - Pfizer, Inc. patents
20100130501 - Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h, 6h) carbaldehyde derivatives
20100120794 - Cycloalkylamino acid derivatives
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pfizer, Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer, Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support - Terms & Conditions
|
REGISTER now for FREE 
